Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Docs to HHS: Keep ephedra available

This article was originally published in The Tan Sheet

Executive Summary

Prohibiting the sale of ephedra "would have a negative impact on public health in general, and on the personal health of my patients," 27 doctors say in form letters to HHS Secretary Tommy Thompson. Physicians say they "have examined the scientific literature on ephedra, which supports the weight-loss benefits and safety when...used according to current standards....I have seen positive and sometimes dramatic effects in may patients who have taken ephedra, without medically significant side effects." The signers, whose specialties include ob/gyn, urology, family medicine and internal medicine, also urge Thompson to support "labeling initiatives that specify serving limits and direct consumers to consult with health professionals before taking ephedra." Letter was drafted by Ephedra Education Council...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel